U.S. weighs new measures for travelers from China as Japan says it will require negative Covid tests

U.S. weighs new measures for travelers from China as Japan says it will require negative Covid tests


For more than two years, overseas travelers have had to quarantine upon arrival in China because of Covid restrictions. Pictured here at Beijing International Airport on June 18, 2022, are passengers waiting to be taken to quarantine-designated destinations.

Leo Ramirez | Afp | Getty Images

The U.S. government is considering imposing new Covid rules for travelers from China, officials said, citing concerns over virus-related data released by the Chinese government.

“There are mounting concerns in the international community on the ongoing COVID-19 surges in China and the lack of transparent data, including viral genomic sequence data, being reported from the PRC,” officials said in a statement late Tuesday.

“Without this data, it is becoming increasingly difficult for public health officials to ensure that they will be able to identify any potential new variants and take prompt measures to reduce the spread,” the officials said.

The officials pointed to Japan’s recent measures which require a negative Covid test for travelers arriving from mainland China from Dec. 30 – as China faces a sharp surge in infections nationwide following an abrupt reopening.

Travelers from China without a valid vaccination certificate will also be required to take a pre-departure test, the notice from Japan’s health ministry added. The measures will not apply to those traveling from Hong Kong and Macao, according to the notice.

Read more about China from CNBC Pro

When asked for comment on Japan’s measures, the Chinese Ministry of Foreign Affairs emphasized a need for a “science-based” measures, without elaborating further.

“The current COVID situation in the world continues to call for a science-based response approach and joint effort to ensure safe cross-border travel, keep global industrial and supply chains stable, and restore world economic growth,” deputy director-general Wang Wenbin told reporters in a Tuesday briefing.

The U.S. officials mentioned Malaysia is also taking measures while India and the World Health Organization have expressed their concern about the situation in China.

“The U.S. is following the science and advice of public health experts, consulting with partners, and considering taking similar steps we can take to protect the American people,” the officials said.

— CNBC’s Evelyn Cheng contributed to this report.



Source

Shares of breast cancer therapy developer Olema Pharmaceutical could more than double from here
Health

Shares of breast cancer therapy developer Olema Pharmaceutical could more than double from here

Wall Street is optimistic that Olema Pharmaceutical could be developing the next major breakthrough breast cancer treatment. Earlier this month, the company announced promising clinical data for its lead candidate palazestrant, an oral medication that is being evaluated in several trials for estrogen receptor-positive, or ER+, breast cancer. Shares of the clinical-stage biopharmaceutical company are up […]

Read More
This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is ‘growing substantially’
Health

This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is ‘growing substantially’

It’s been a stellar few months for shares of San Francisco-based biotech company Rigel Pharmaceuticals, which has approved treatments for rheumatology and oncology — as well as potential new drugs in the pipeline. The stock has jumped about 50% in just the last three months, earning it a spot on CNBC’s list of top performing […]

Read More
We’re raising our Eli Lilly price target — what a difference a quarter makes
Health

We’re raising our Eli Lilly price target — what a difference a quarter makes

Eli Lilly shares jumped Thursday after the drugmaker posted a strong third quarter, driven by sales of its popular GLP-1 medications. The company also raised its full-year sales outlook for the second time in a row, inspiring confidence in the trajectory of the franchise. Revenue in the three months ended Sept. 30 jumped 54% year […]

Read More